130 related articles for article (PubMed ID: 37551489)
1. [Comparison of Cyclosporine A and Cyclosporine A Combined with Corticosteroid in the Treatment of Acquired Pure Red Cell Aplasia].
Zhang RX; Huang YZ; Han B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1138-1142. PubMed ID: 37551489
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Sawada K; Hirokawa M; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2007 Aug; 92(8):1021-8. PubMed ID: 17640861
[TBL] [Abstract][Full Text] [Related]
3. Induced complete remission faster in adult patients with acquired pure red cell aplasia by combining cyclosporine A with corticosteroids.
Wu X; Yang Y; Lu X; Yin H; Wang S; Wang S; Hong M; Zhu Y; Lu R; Qiao C; Wu Y; He G; Li J
Medicine (Baltimore); 2019 Oct; 98(41):e17425. PubMed ID: 31593095
[TBL] [Abstract][Full Text] [Related]
4. Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center.
Wu X; Wang S; Lu X; Shen W; Qiao C; Wu Y; Lu R; Wang S; Zhang J; Hong M; Zhu Y; Li J; He G
Int J Hematol; 2018 Aug; 108(2):123-129. PubMed ID: 29589280
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
Huang Y; Chen M; Yang C; Ruan J; Wang S; Han B
Leukemia; 2022 May; 36(5):1351-1360. PubMed ID: 35256763
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective.
Liu X; Lu X; Chen L; Yang Y; Wu X; Lu R; Wang S; Zhang J; Hong M; Zhu Y; He G; Li J
Ann Hematol; 2020 Mar; 99(3):443-449. PubMed ID: 31970447
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.
Wu X; Cheng L; Liu X; Sun Y; Li B; He G; Li J
Ann Hematol; 2022 Jul; 101(7):1493-1498. PubMed ID: 35460389
[TBL] [Abstract][Full Text] [Related]
8. Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency.
Chen Z; Liu X; Chen M; Yang C; Han B
Ann Hematol; 2020 Apr; 99(4):737-741. PubMed ID: 32030447
[TBL] [Abstract][Full Text] [Related]
9. A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia.
Yang L; Niu H; Zhang T; Cao Q; Liu M; Liu Y; Yan L; Qi W; Wang T; Liu C; Li L; Xing L; Wang H; Shao Z; Fu R
Ann Hematol; 2024 Jun; 103(6):1877-1885. PubMed ID: 38308019
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.
Dao AT; Yamazaki H; Takamatsu H; Sugimori C; Katagiri T; Maruyama H; Zaimoku Y; Maruyama K; Ly TQ; Espinoza L; Nakao S
Ann Hematol; 2016 Apr; 95(5):771-81. PubMed ID: 26968551
[TBL] [Abstract][Full Text] [Related]
11. Acquired pure red cell aplasia: updated review of treatment.
Sawada K; Fujishima N; Hirokawa M
Br J Haematol; 2008 Aug; 142(4):505-14. PubMed ID: 18510682
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis.
Lobbes H; Lega JC; Le Guenno G; Ruivard M; Mainbourg S
Blood Adv; 2023 Nov; 7(21):6451-6465. PubMed ID: 37624775
[TBL] [Abstract][Full Text] [Related]
13. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.
Hirokawa M; Sawada K; Fujishima N; Nakao S; Urabe A; Dan K; Fujisawa S; Yonemura Y; Kawano F; Omine M; Ozawa K;
Haematologica; 2008 Jan; 93(1):27-33. PubMed ID: 18166782
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study.
Chen Z; Chen M; Yang C; Han B
Ann Hematol; 2020 Jul; 99(7):1485-1491. PubMed ID: 32488602
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus.
Long Z; Yu F; Du Y; Li H; Chen M; Zhuang J; Han B
Ann Hematol; 2018 Nov; 97(11):2047-2054. PubMed ID: 29982851
[TBL] [Abstract][Full Text] [Related]
16. The clinical characteristics and therapy response of patients with acquired pure red cell aplasia.
Fu R; Zhang T; Liu B; Song J; Wang G; Li L; Wang H; Xing L; Wu Y; Guan J; Shao Z
Hematology; 2018 Oct; 23(9):639-645. PubMed ID: 29754581
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of acquired pure red cell aplasia.
Sawada K; Hirokawa M; Fujishima N
Hematol Oncol Clin North Am; 2009 Apr; 23(2):249-59. PubMed ID: 19327582
[TBL] [Abstract][Full Text] [Related]
18. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
[TBL] [Abstract][Full Text] [Related]
19. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
Chen C; Fang JP; Huang SL; Zhong FY
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
